Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Summary

RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. Giving sunitinib before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. PURPOSE: This phase II trial is studying the side effects and how well sunitinib works in treating patients with locally advanced bladder cancer.

Timeline

Start

2007-09

Primary completion

2010-03

Completion

2011-03

Drugs

Indications